Therapeutic targeting of autophagy in disease: biology and pharmacology

Y Cheng, X Ren, WN Hait, JM Yang - Pharmacological reviews, 2013 - ASPET
targeted by therapies for various disorders. A better understanding of the biology of autophagy
and the pharmacology of … -based therapeutic interventions for several human diseases. …

[HTML][HTML] Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker

H Liu, JY Liu, X Wu, JT Zhang - … biochemistry and molecular biology, 2010 - ncbi.nlm.nih.gov
Human fatty acid synthase (FASN) is a 270-kDa cytosolic dimeric enzyme that is responsible
for palmitate synthesis. FASN is slowly emerging and rediscovered as a marker for …

Pharmacology of nociceptin and its receptor: a novel therapeutic target

G Calo', R Guerrini, A Rizzi… - … of pharmacology, 2000 - Wiley Online Library
… While describing and discussing the findings obtained with these approaches, we will
compare the actions of these various pharmacological and biological tools with those obtained …

The biology and therapeutic targeting of the proprotein convertases

NG Seidah, A Prat - Nature reviews Drug discovery, 2012 - nature.com
… This Review provides an overview of the biological roles and therapeutic potential of proprotein
… challenges in the development of novel proprotein convertase-targeted therapeutics. …

Therapeutic targets of vitamin C on liver injury and associated biological mechanisms: a study of network pharmacology

M Su, C Guo, M Liu, X Liang, B Yang - International immunopharmacology, 2019 - Elsevier
… C (VC) exerts potent pharmacological activities against liver … pharmacology-based strategy
to predict therapeutic targets of VC against LI, and further to investigate the pharmacological

Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair

J Iredale - Pharmacological research, 2008 - Elsevier
Liver fibrosis represents the generic wound healing response to chronic insults regardless
of their mechanism. The causes of chronic liver injury and fibrosis have a wide geographic …

Pharmacology of brain Na+/Ca2+ exchanger: from molecular biology to therapeutic perspectives

L Annunziato, G Pignataro, GF Di Renzo - Pharmacological reviews, 2004 - ASPET
… Considering that a comprehensive review on the pharmacological modulation of brain NCX
… the molecular pharmacology of NCX in the brain and the possible therapeutic implications of …

Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis: Biology, Epidemiology, and Possible Therapeutic Target

A Zalewski, C Macphee - … , thrombosis, and vascular biology, 2005 - Am Heart Assoc
… Its biological role has been controversial with initial reports purporting atheroprotective effects
of … ; however, more studies are needed to better define the biological role of this enzyme. …

Liver X receptor biology and pharmacology: new pathways, challenges and opportunities

T Jakobsson, E Treuter, JÅ Gustafsson… - … in pharmacological …, 2012 - cell.com
pharmacology. The two liver X receptors LXRα and LXRβ are among the emerging newer
drug targets within … , they have potential as therapeutic targets for diseases as diverse as lipid …

RAL GTPases: biology and potential as therapeutic targets in cancer

C Yan, D Theodorescu - Pharmacological reviews, 2018 - ASPET
… , limited structural information is available to understand their binding to RAS or RAL, thus
structural studies will be needed before they can be exploited as feasible therapeutic targets